Drug intelligence / Profile preview

Dihuang Zhixue Capsule

Development stage: Unknown
Administration: Oral

Overview

Dihuang Zhixue Capsule (DZC) is a Traditional Chinese Medicine (TCM) herbal preparation formulated to "cool the blood and dispel toxic substances." It is primarily used in the treatment of refractory idiopathic thrombocytopenic purpura (RITP), particularly in pediatric populations. Clinical studies have demonstrated that DZC is effective in increasing platelet counts and improving hemorrhagic symptoms, showing superior efficacy and a more favorable safety profile compared to conventional immunosuppressants like cyclosporin A. The formulation typically includes *Rehmannia glutinosa* (Dihuang) as a primary component, which is traditionally utilized in TCM to clear heat and stop bleeding.

Brand names: Dihuang Zhixue Capsule
Other names: DZCDihuang Zhixue Jiaonang

Beyond the preview

Go deeper on Dihuang Zhixue Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dihuang Zhixue Capsule.

Explore the full profile